% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Khne:279433,
author = {Köhne, Maren and Shakiba, Mehrnoush Hadaddzadeh and
Schmidleithner, Lisa and Schulte-Schrepping, Jonas and
Scholz, Rebekka and Elmzzahi, Tarek and Sommer, Daniel and
Li, Yuanfang and Carraro, Caterina and De Domenico, Elena
and Wißfeld, Jannis and Händler, Kristian and Hamada, Doaa
and Frolov, Aleksej and Cheng, Xiaoxiao and Baumgart,
Ann-Kathrin and Holsten, Lisa and Osei-Sarpong, Collins and
Bourry, Svenja and Thabet, Yasser and Renken, Hannes and
Paulusch, Stefan and Sadlon, Timothy and Buch, Thorsten and
Wunderlich, F Thomas and Wickenhauser, Claudia and Alferink,
Judith and Kuhlmann, Tanja and Geyer, Matthias and Bonaguro,
Lorenzo and Barry, Simon C and Schultze, Joachim L and
Beyer, Marc D},
title = {{S}atb1 directs the differentiation of {TH}17 cells through
suppression of {IL}-2 expression.},
journal = {Cell reports},
volume = {44},
number = {7},
issn = {2211-1247},
address = {Maryland Heights, MO},
publisher = {Cell Press},
reportid = {DZNE-2025-00764},
pages = {115866},
year = {2025},
abstract = {T helper (TH)17 cells are crucial for host defense in
barrier organs, and their altered functionality can disrupt
tissue homeostasis, increasing the risk of autoimmune
diseases. Thus, it is essential to understand the mechanisms
controlling TH17 differentiation to develop strategies
influencing their role in diseases. Here, we identified
Special AT-rich sequence-binding protein 1 (Satb1) as a
pioneering factor for TH17 development. Satb1 is highly
expressed in TH17 cells, and loss of Satb1 prevents the
differentiation of TH17 cells. Consequently, expression of
Satb1 in CD4+ T cells is required for the formation of
TH17-driven autoimmune diseases. Mechanistically, Satb1
mediates TH17 development through regulating accessibility
of the Il2 gene locus and thereby preventing interleukin
(IL)-2 signaling early during TH17 differentiation. Hence,
suppression of IL-2 expression by Satb1 during TH17
formation is pivotal, suggesting that Satb1 could serve as a
novel therapeutic target for treating autoimmune diseases
driven by TH17 cells.},
keywords = {CD4(+) T cell differentiation (Other) / CP: Immunology
(Other) / EAE (Other) / IL-2 (Other) / Satb1 (Other) /
T(H)17 cells (Other) / autoimmune disease (Other) / colitis
(Other) / scRNA-seq (Other) / single-cell MultiOMICs
(Other)},
cin = {AG Beyer / AG Schultze / AG Bonaguro},
ddc = {610},
cid = {I:(DE-2719)1013035 / I:(DE-2719)1013038 /
I:(DE-2719)1016005},
pnm = {351 - Brain Function (POF4-351) / 354 - Disease Prevention
and Healthy Aging (POF4-354)},
pid = {G:(DE-HGF)POF4-351 / G:(DE-HGF)POF4-354},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:40531625},
doi = {10.1016/j.celrep.2025.115866},
url = {https://pub.dzne.de/record/279433},
}